Garry Jennings AO is a cardiologist, researcher and a former President of the Society. He co‑chaired the 2023 Australian Cardiovascular Disease Risk Prediction Guideline and, in 2026, led steering groups for the Australian Hypertension and Lipid Guidelines as well as the national Obesity and Cardiovascular Disease consensus project. He is Chief Medical Advisor of the National Heart Foundation of Australia and a Life Governor of the Baker Heart and Diabetes Institute, where he was Director and CEO for 14 years. His previous leadership roles include Director of Cardiovascular Medicine at The Alfred Hospital and Executive Director of Sydney Health Partners. Early in his career, working under Paul Korner, Professor Jennings established the dose–response relationship between physical activity and blood pressure. In collaboration with Murray Esler and colleagues, he also helped clarify the role of sympathetic nervous activity in hypertension and heart failure. Professor Jennings has contributed to landmark international studies. With more than 700 peer‑reviewed publications and over 60,000 citations, he continues to advance cardiovascular health through research, clinical practice, and national policy leadership.